Details for New Drug Application (NDA): 204570
✉ Email this page to a colleague
NDA 204570 describes TESTOSTERONE, which is a drug marketed by Actavis Labs Ut Inc, Alembic, Amneal, Encube, Lupin, Padagis Israel, Perrigo Israel, Twi Pharms, Xiromed, Ani Pharms, Strides Pharma, Dr Reddys, Watson Labs, Apotex, Cipla, Lupin Ltd, Am Regent, Eugia Pharma, Hikma, Hikma Farmaceutica, Padagis Us, Rising, Sandoz, Sun Pharm Inds Ltd, Watson Pharms Inc, Wilshire Pharms Inc, Azurity, Nexus, Bel Mar, Elkins Sinn, and Lilly, and is included in sixty NDAs. It is available from fourteen suppliers. There are two patents protecting this drug. Additional details are available on the TESTOSTERONE profile page.
The generic ingredient in TESTOSTERONE is testosterone propionate. There are sixty-nine drug master file entries for this compound. Additional details are available on the testosterone propionate profile page.
The generic ingredient in TESTOSTERONE is testosterone propionate. There are sixty-nine drug master file entries for this compound. Additional details are available on the testosterone propionate profile page.
Summary for 204570
| Tradename: | TESTOSTERONE |
| Applicant: | Actavis Labs Ut Inc |
| Ingredient: | testosterone |
| Patents: | 0 |
Pharmacology for NDA: 204570
| Mechanism of Action | Androgen Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 204570
Suppliers and Packaging for NDA: 204570
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| TESTOSTERONE | testosterone | GEL, METERED;TRANSDERMAL | 204570 | ANDA | Actavis Pharma, Inc. | 0591-2924 | 0591-2924-18 | 1 BOTTLE, PUMP in 1 CARTON (0591-2924-18) / 88 g in 1 BOTTLE, PUMP |
| TESTOSTERONE | testosterone | GEL, METERED;TRANSDERMAL | 204570 | ANDA | Actavis Pharma, Inc. | 0591-2925 | 0591-2925-30 | 30 PACKET in 1 CARTON (0591-2925-30) / 1.25 g in 1 PACKET (0591-2925-32) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | GEL, METERED;TRANSDERMAL | Strength | 1.62% (20.25MG/1.25GM ACTUATION) | ||||
| Approval Date: | Apr 10, 2019 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | GEL;TRANSDERMAL | Strength | 1.62% (20.25MG/1.25GM PACKET) | ||||
| Approval Date: | Jul 17, 2020 | TE: | AB2 | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | GEL;TRANSDERMAL | Strength | 1.62% (40.5MG/2.5GM PACKET) | ||||
| Approval Date: | Jul 17, 2020 | TE: | AB2 | RLD: | No | ||||
Complete Access Available with Subscription
